about
Enhanced generation of induced pluripotent stem cells from a subpopulation of human fibroblastsStem cells, the molecular circuitry of pluripotency and nuclear reprogrammingXenopus tropicalis as a model organism for genetics and genomics: past, present, and futureA gene expression signature shared by human mature oocytes and embryonic stem cells.Cloned myogenic cells can transdifferentiate in vivo into neuron-like cells.The novel tool of cell reprogramming for applications in molecular medicine.Nuclear transfer to eggs and oocytes.Cellular phenotype switching and microvesicles.A blueprint for engineering cell fate: current technologies to reprogram cell identity.Mice cloned from olfactory sensory neurons.Genome transplantation in bacteria: changing one species to another.Reprogramming to a muscle fate by fusion recapitulates differentiation.Nuclear reprogramming in mammalian somatic cell nuclear cloningCell-free embryonic stem cell extract-mediated derivation of multipotent stem cells from NIH3T3 fibroblasts for functional and anatomical ischemic tissue repair.Programming the genome in embryonic and somatic stem cells.Stem cell therapy and the retina.Rapid induction of pluripotency genes after exposure of human somatic cells to mouse ES cell extracts.Pluripotency and nuclear reprogramming.National Institutes of Health Center for Regenerative Medicine: putting science into practice.Maintenance of multipotency in human dermal fibroblasts treated with Xenopus laevis egg extract requires exogenous fibroblast growth factor-2Lessons for cardiac regeneration and repair through development.Stem cell therapy in oral and maxillofacial region: An overview.Reprogramming cell fates: insights from combinatorial approaches.Stress cycles in stem cells/iPSCs development: implications for tissue repair.Human kidney cell reprogramming: applications for disease modeling and personalized medicineTuning cell fate: from insights to vertebrate regenerationCell therapy worldwide: an incipient revolution.Cellular plasticity: 1712 to the present day.Modification of the Genome of Domestic Animals.Induction of dedifferentiation, genomewide transcriptional programming, and epigenetic reprogramming by extracts of carcinoma and embryonic stem cells.Epigenetic reprogramming of OCT4 and NANOG regulatory regions by embryonal carcinoma cell extract.CMD kinetics and regenerative medicineInduced pluripotent stem cell technology and stem cell therapy for diabetesEpigenetic Basis for the Differentiation Potential of Mesenchymal and Embryonic Stem Cells.Cell memory-based therapy.AID for reprogramming.Nuclear transfer: epigenetics pays a visit.Programming biological operating systems: genome design, assembly and activation.Cancer, conflict, and the development of nuclear transplantation techniques.Primate therapeutic cloning in practice.
P2860
Q27341904-7CEBB7D3-3B0E-4637-AAFB-BEF50BCB7709Q29614416-F0C7F99B-DC48-498B-915C-DC16B4BFAD23Q30414847-69B727C3-51AA-49ED-AFD5-C1A4FF9EC21BQ33398202-0511EC19-6784-4C12-A1ED-8ADB5CB428B2Q33526303-BB0EBAB6-6574-4C15-A083-424B7DB4EC4AQ33843720-12E688FB-49D1-473B-BD82-92DD216FB425Q34026825-8FE1A1D1-EF91-4740-9A8E-9950B2FDDAFAQ34203939-0185E71F-595F-4A73-823E-0D90AF0539C9Q34320191-9F1E2A7D-C133-4E94-B244-8C64A3949957Q34545949-687C04EC-7EC1-4797-B4D1-8E9763603830Q34643428-868921B0-F57E-452E-B6FA-DDCD58912ECBQ34964478-52D0A4AC-3F58-48D4-8D6B-9C3D75CC04F0Q35827771-D2E0787A-68F9-4BAC-B489-F39E9E422F1BQ36731424-9FCC6142-2253-4B58-A1B8-199B1445AE78Q36924370-2A2BE664-5CE8-4A2D-97C1-A10296373030Q36959932-F417EDEE-6B1D-46B3-A417-D23EDBF6CB9EQ36960851-8A9556B9-14DE-474A-8809-DFFC67D03057Q37122739-D0EB729B-8B09-40DB-8C70-CF544EE31678Q37443477-8FD1ED3D-6923-42A7-8928-2A17A35D0669Q37577047-0D37EC6E-9F14-4B30-8B4B-11E7BB1D7DE4Q37778540-56438CBD-E239-4BC8-A659-B8B4F2729C7AQ37995587-6B1B613F-1167-42E7-B838-E146000A7382Q38035434-5B06C713-86B8-45F1-994B-4AF312689A2DQ38121453-85A9D9A9-CE9D-4581-8EE6-2F5B25FF816DQ38129317-0C962FC7-00A9-4E3B-9E2C-1D84961B8E4CQ38204883-7E806F66-D4B6-4582-9352-FEF60CBE126BQ38391002-3E2A04A0-B6FA-4BC5-8595-B1B5550DA415Q38916687-9808070B-013B-4003-B07A-FFE446328C0EQ39095144-A65AFC59-87F9-4135-A7AE-F90D7F94992CQ39847773-E4A3BA4D-0F11-4B3F-8B2E-545FF4503CE1Q40168400-E452AB84-17B6-42AE-8A68-E025C5861B6BQ41125370-49B8E386-AE9A-4B12-84C9-A48CE4C66C1DQ42089748-2C300CD5-20C2-4160-9030-B0E4D17A6C8BQ42178123-515CF4F7-B97D-4157-B618-78DBBEC7BE90Q42605371-28839D3B-4206-4B3B-9FD6-50C07AF149DBQ43146804-DD4F321B-E6DC-4E5A-BADA-BEEAE0279CDAQ45086887-7AFC58A0-848D-4D9F-A534-545C59E360B7Q46081413-50671578-E604-4238-A50A-67A15FC10CE5Q47873036-0AD617D2-9D73-4F0A-888A-88387F0A0E4FQ48541010-227D75C6-16B9-4175-B46C-EFFF4AABF29C
P2860
description
2003 nî lūn-bûn
@nan
2003 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
The first half-century of nuclear transplantation.
@ast
The first half-century of nuclear transplantation.
@en
type
label
The first half-century of nuclear transplantation.
@ast
The first half-century of nuclear transplantation.
@en
prefLabel
The first half-century of nuclear transplantation.
@ast
The first half-century of nuclear transplantation.
@en
P2860
P356
P1476
The first half-century of nuclear transplantation.
@en
P2093
P2860
P304
P356
10.1073/PNAS.1337135100
P407
P50
P577
2003-06-23T00:00:00Z